Hashimoto, Shoko http://orcid.org/0000-0002-5778-4884
Matsuba, Yukio
Kamano, Naoko
Mihira, Naomi
Sahara, Naruhiko
Takano, Jiro
Muramatsu, Shin-ichi http://orcid.org/0000-0002-3185-7790
Saido, Takaomi C. http://orcid.org/0000-0003-1970-6903
Saito, Takashi http://orcid.org/0000-0002-9659-9251
Funding for this research was provided by:
Japan Agency for Medical Research and Development
MEXT | Japan Society for the Promotion of Science
Uehara Memorial Foundation
Article History
Received: 1 October 2018
Accepted: 24 April 2019
First Online: 3 June 2019
Change Date: 1 July 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: S.H., Y.M., T.S. and T.C.S. serve as a member, a director, an advisor and a CEO, respectively, for RIKEN BIO Co. Ltd. S.M. servers as a director and owns equity in a gene therapy company (Gene Therapy Research Institution Co., Ltd.). The remaining authors declare no competing interests.